Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A zero-spend month concentrates spending to essentials, directing more money toward debt. Plan, track, and celebrate smaller, steady wins.
16,055 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Ultra-prime Manhattan sales are accelerating even as policy debates intensify. Brokers say buyers and sellers remain ...
The U.S. economy caught chill from tariff-driven price increases and Winter Storm Fern, with executives signaling a c...
A renowned investment firm signals one cryptocurrency could jump 120% in the coming months. This guide breaks down th...
Solana faces a sharp pullback as SOL tests pivotal support levels. A new solana (sol) price alert highlights mounting...
Institutional moves shape the AI stock landscape. This article dives into Philippe Laffont’s Coatue strategy, why Nvi...
Investors are watching Meta Platforms for a potential stock split. This guide explains how splits work, what they mea...
A small group of mega-cap stocks can tilt the entire market. This in-depth look explains how the magnificent seven sh...
Block, the fintech and crypto payments company, is pursuing a major restructuring that could cost up to $500 million ...
Prediction markets offer probabilities, not guarantees. This article explains what polymarket says bitcoin just 3% od...
Ethereum stands on the edge of a rare capitulation pattern, with seven straight monthly declines likely. Traders eye ...